Who Supplies Vaccine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Vaccine exports, with 325+ registered manufacturers shipping to buyers across 192+ countries — yet a handful of companies dominate the shipments. SERUM INSTITUTE OF INDIA PRIVATE LIMITED holds the largest share at 12.8% (export value: $133.0M). Close behind, BHARAT BIOTECH INTERNATIONAL LIMITED (8.0%, $83.0M). BIOLOGICAL E. LIMITED (6.8%, $70.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Vaccine? Top Manufacturers & Their Buyers
Flow of Vaccine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Vaccine Supplier Network — Key Market Intelligence
The Vaccine export market from India is led by SERUM INSTITUTE OF INDIA PRIVATE LIMITED, which alone commands a 12.8% share, shipping $133.0M worth of product across 3.2K shipments. The second-largest exporter, BHARAT BIOTECH INTERNATIONAL LIMITED, contributes $83.0M (8.0%) to the overall market. Combined, the top two suppliers alone account for 20.7% of all Vaccine exports, indicating a relatively concentrated supply base.
Across all 325 tracked manufacturers, the total Vaccine export value stands at $1.0B from 14.4K shipments. The market average shipment value is $72.5K. The single largest buyer relationship in terms of trade value is NATIONAL VACCINES AND IMMUNIZATION, receiving $37.8M worth of product.
The combined buyer network spans 21 named purchasing companies, including XXRUMXXIFEXXCIEXXES XXD, SERUM LIFE SCIENCES LTD, UNICEF SUPPLY DIVISION, XXICEXXSUPXXY DXXISIXX, NATIONAL VACCINES AND IMMUNIZATION and 16 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SERUM INSTITUTE OF INDIA PRIVATE LIMITED
SERUM INSTITUTE OF INDIA PRIVATE LIMITED is the first-largest Vaccine exporter from India, with a market share of 12.8% and a total export value of $133.0M across 3.2K shipments. Their average shipment value of $41.2K is below the market average of $72.5K, reflecting a high-volume, competitive pricing strategy.
SERUM INSTITUTE OF INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• XXRUMXXIFEXXCIEXXES XXD — $31.3M across 760 shipments (23.6% of this supplier's total exports)
• SERUM LIFE SCIENCES LTD — $31.3M across 760 shipments (23.6% of this supplier's total exports)
• UNICEF SUPPLY DIVISION — $26.8M across 650 shipments (20.2% of this supplier's total exports)
• XXICEXXSUPXXY DXXISIXX — $23.5M across 569 shipments (17.7% of this supplier's total exports)
• SERUM LIFE SCIENCES LTD — $20.0M across 486 shipments (15.1% of this supplier's total exports)
Key Insight: SERUM INSTITUTE OF INDIA PRIVATE LIMITED operates with high shipment frequency (3.2K shipments) at a per-shipment value of $41.2K, indicating a broad distribution network with many smaller, regular orders.
2BHARAT BIOTECH INTERNATIONAL LIMITED
BHARAT BIOTECH INTERNATIONAL LIMITED is the second-largest Vaccine exporter from India, with a market share of 8.0% and a total export value of $83.0M across 609 shipments. Their average shipment value of $136.2K is above the market average of $72.5K, suggesting premium or bulk contract pricing.
BHARAT BIOTECH INTERNATIONAL LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NATIONAL VACCINES AND IMMUNIZATION — $37.8M across 278 shipments (45.6% of this supplier's total exports)
• EXPANDED PROGRAM ON IMMUNIZATION — $14.6M across 107 shipments (17.6% of this supplier's total exports)
• PT BIO FARMA PERSERO NA — $12.0M across 88 shipments (14.5% of this supplier's total exports)
• NATIONAL PRIMARY HEALTHCARE — $9.4M across 69 shipments (11.4% of this supplier's total exports)
• PT BIO FARMA (PERSER — $9.1M across 67 shipments (10.9% of this supplier's total exports)
Key Insight: BHARAT BIOTECH INTERNATIONAL LIMITED's per-shipment value of $136.2K is 88% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.
3BIOLOGICAL E. LIMITED
BIOLOGICAL E. LIMITED is the third-largest Vaccine exporter from India, with a market share of 6.8% and a total export value of $70.5M across 859 shipments. Their average shipment value of $82.1K is above the market average of $72.5K, suggesting premium or bulk contract pricing.
BIOLOGICAL E. LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• D.G. CENTRAL MEDICAL STORES DEPT. — $33.0M across 402 shipments (46.8% of this supplier's total exports)
• EXPANDED PROGRAM ON IMMUNIZATION — $13.7M across 166 shipments (19.4% of this supplier's total exports)
• EXPANDED PROGRAMME ON IMMUNIZATION — $8.8M across 107 shipments (12.4% of this supplier's total exports)
• NATIONAL PRIMARY HEALTHCARE — $8.2M across 100 shipments (11.6% of this supplier's total exports)
• NATIONAL PRIMARY HEALTHCARE — $6.9M across 84 shipments (9.8% of this supplier's total exports)
Key Insight: BIOLOGICAL E. LIMITED's per-shipment value of $82.1K is 13% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.
4BIOLOGICAL E LIMITED
BIOLOGICAL E LIMITED is the fourth-largest Vaccine exporter from India, with a market share of 3.2% and a total export value of $33.3M across 313 shipments. Their average shipment value of $106.3K is above the market average of $72.5K, suggesting premium or bulk contract pricing.
BIOLOGICAL E LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BE VACCINES PTE LIMITED — $10.1M across 95 shipments (30.3% of this supplier's total exports)
• XX VAXXINEXXPTEXXIMI — $7.8M across 74 shipments (23.6% of this supplier's total exports)
• MINISTRY OF HEALTH — $6.1M across 57 shipments (18.3% of this supplier's total exports)
• D.G. CENTRAL MEDICAL STORES DEPT. — $5.0M across 47 shipments (15.1% of this supplier's total exports)
• FEDERAL MINISTRY OF — $4.2M across 40 shipments (12.7% of this supplier's total exports)
Key Insight: BIOLOGICAL E LIMITED's per-shipment value of $106.3K is 47% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.
5INDIAN IMMUNOLOGICALS LIMITED
INDIAN IMMUNOLOGICALS LIMITED is the fifth-largest Vaccine exporter from India, with a market share of 3.0% and a total export value of $31.5M across 403 shipments. Their average shipment value of $78.1K is above the market average of $72.5K, suggesting premium or bulk contract pricing.
INDIAN IMMUNOLOGICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CENTURION ILAC SANAYI VE TICARET AN — $11.6M across 149 shipments (37.0% of this supplier's total exports)
• 2 WORLD TRADERS INC — $9.9M across 127 shipments (31.5% of this supplier's total exports)
• DUC MINH MEDICAL JOI — $5.6M across 72 shipments (17.8% of this supplier's total exports)
• CENTURION ILAC SANAYI VE TICARET AN — $3.1M across 39 shipments (9.7% of this supplier's total exports)
• 2 WORLD TRADERS INC — $1.3M across 16 shipments (4.0% of this supplier's total exports)
Key Insight: INDIAN IMMUNOLOGICALS LIMITED's per-shipment value of $78.1K is 8% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.
6PANACEA BIOTEC LIMITED
PANACEA BIOTEC LIMITED is the fifth-largest Vaccine exporter from India, with a market share of 1.9% and a total export value of $19.8M across 234 shipments. Their average shipment value of $84.7K is above the market average of $72.5K, suggesting premium or bulk contract pricing.
PANACEA BIOTEC LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• D.G. CENTRAL MEDICAL STORES DEPT. — $7.2M across 85 shipments (36.2% of this supplier's total exports)
• D.G. CENTRAL MEDICAL STORES DEPT. — $4.8M across 56 shipments (24.1% of this supplier's total exports)
• PT BANK MANDIRI (PER — $2.8M across 33 shipments (14.0% of this supplier's total exports)
• MINISTERIO DA SAUDE/ — $2.6M across 31 shipments (13.4% of this supplier's total exports)
• UNICEF KABUL — $2.4M across 29 shipments (12.3% of this supplier's total exports)
Key Insight: PANACEA BIOTEC LIMITED's per-shipment value of $84.7K is 17% above the market average of $72.5K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Vaccine Flows
Once Vaccine leaves the manufacturing plants of companies like SERUM INSTITUTE OF INDIA PRIVATE LIMITED and BHARAT BIOTECH INTERNATIONAL LIMITED, it travels to 5 destination markets with a combined import value of $1.0B. Pakistan absorbs the largest share at 8.5% ($88.1M), followed by Nigeria (8.1%) and Bangladesh (7.5%).
In Pakistan — the top destination — named importers include EXPANDED PROGRAM ON IMMUNIZATION, EXPANDED PROGRAMME ON IMMUNIZATION, BE VACCINES PTE LIMITED. In Nigeria, key buyers are NATIONAL PRIMARY HEALTH CARE, NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY NPHCDA, NATIONAL PRIMARY HEALTHCARE.
This geographic spread reflects Vaccine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Vaccine Go? Top Importing Countries & Their Buyers
Trade flow of Vaccine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Pakistan
Pakistan ranks as the first-largest destination for Vaccine imports from India, with a total trade value of $88.1M across 105 shipments — representing a 8.5% share of all Vaccine exports. The average shipment value of $838.7K is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Vaccine importers in Pakistan: EXPANDED PROGRAM ON IMMUNIZATION is the largest buyer, accounting for 37.9% ($33.4M) of this market's total imports.
• EXPANDED PROGRAM ON IMMUNIZATION — $33.4M (37.9% of Pakistan's total)
• EXPANDED PROGRAMME ON IMMUNIZATION — $14.0M (15.9% of Pakistan's total)
• BE VACCINES PTE LIMITED — $10.1M (11.5% of Pakistan's total)
Key Insight: Pakistan's per-shipment average of $838.7K (1056% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Pakistan is a key market for Vaccine imports from India.
2Nigeria
Nigeria ranks as the second-largest destination for Vaccine imports from India, with a total trade value of $84.5M across 156 shipments — representing a 8.1% share of all Vaccine exports. The average shipment value of $541.8K is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Vaccine importers in Nigeria: NATIONAL PRIMARY HEALTH CARE is the largest buyer, accounting for 58.3% ($49.3M) of this market's total imports.
• NATIONAL PRIMARY HEALTH CARE — $49.3M (58.3% of Nigeria's total)
• NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY NPHCDA — $9.4M (11.1% of Nigeria's total)
• NATIONAL PRIMARY HEALTHCARE — $9.3M (11.0% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $541.8K (647% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Vaccine imports from India.
3Bangladesh
Bangladesh ranks as the third-largest destination for Vaccine imports from India, with a total trade value of $78.1M across 107 shipments — representing a 7.5% share of all Vaccine exports. The average shipment value of $730.0K is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Vaccine importers in Bangladesh: D.G. CENTRAL MEDICAL STORES DEPT is the largest buyer, accounting for 47.7% ($37.2M) of this market's total imports.
• D.G. CENTRAL MEDICAL STORES DEPT — $37.2M (47.7% of Bangladesh's total)
• D G CENTRAL MEDICAL STORES DEPT — $11.8M (15.1% of Bangladesh's total)
• D.G. CENTRAL MEDICAL STORES DEPT. — $9.9M (12.6% of Bangladesh's total)
Key Insight: Bangladesh's per-shipment average of $730.0K (906% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Bangladesh is a key market for Vaccine imports from India.
4Kenya
Kenya ranks as the fourth-largest destination for Vaccine imports from India, with a total trade value of $55.9M across 37 shipments — representing a 5.4% share of all Vaccine exports. The average shipment value of $1.5M is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vaccine importers in Kenya: NATIONAL VACCINES AND IMMUNIZATION is the largest buyer, accounting for 69.2% ($38.7M) of this market's total imports.
• NATIONAL VACCINES AND IMMUNIZATION — $38.7M (69.2% of Kenya's total)
Key Insight: Kenya's per-shipment average of $1.5M (1984% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Vaccine imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Vaccine imports from India, with a total trade value of $47.3M across 33 shipments — representing a 4.5% share of all Vaccine exports. The average shipment value of $1.4M is above the global average of $72.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vaccine importers in Philippines: 2 WORLD TRADERS INC is the largest buyer, accounting for 23.2% ($11.0M) of this market's total imports.
• 2 WORLD TRADERS INC — $11.0M (23.2% of Philippines's total)
Key Insight: Philippines's per-shipment average of $1.4M (1876% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Vaccine imports from India.
People Also Ask — Vaccine Supplier & Trade Network
Who are the top suppliers of Vaccine from India?+
Which companies buy Vaccine from Indian manufacturers?+
Where does Vaccine exported from India go?+
What is the market share of the top Vaccine supplier from India?+
What is the average shipment value for Vaccine exports from India?+
Is Vaccine manufactured in India and exported globally?+
Which country imports the most Vaccine from India?+
Who are the buyers of Vaccine in Nigeria?+
How concentrated is the Vaccine supplier market in India?+
How do I find verified buyers for Vaccine in specific countries?+
Vaccine Trade Network — Key Takeaways
- 1SERUM INSTITUTE OF INDIA PRIVATE LIMITED is India's dominant Vaccine exporter with a 12.8% market share and $133.0M in total exports — making it the single most important sourcing entity in this market.
- 2The top 325 suppliers collectively account for 35.6% of all tracked Vaccine exports, with a combined trade value of $1.0B.
- 3Pakistan is the largest destination market, absorbing 8.5% of India's Vaccine exports ($88.1M). Nigeria (8.1%) and Bangladesh (7.5%) follow.
- 4With 14.4K total shipments averaging $72.5K each, the Vaccine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include XXRUMXXIFEXXCIEXXES XXD, SERUM LIFE SCIENCES LTD, NATIONAL VACCINES AND IMMUNIZATION, EXPANDED PROGRAM ON IMMUNIZATION — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 192 countries
Network value: $1.0B
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Vaccine.
- 2.Flow Mapping: 325 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 14,355 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 192 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14,355 Verified Shipments
325 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists